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Abstract
Background: Except for the I/D polymorphism in the angiotensin I-converting enzyme (ACE) gene, there were few
reports about the relationship between other genetic polymorphisms in this gene and the changes in cardiac
structure and function of athletes. Thus, we investigated whether the G2350A polymorphism in the ACE gene is
associated with the changes in cardiac structure and function of ball game players. Total 85 healthy ball game
players were recruited in this study, and they were composed of 35 controls and 50 ball game players, respectively.
Cardiac structure and function were measured by 2-D echocardiography, and the G2350A polymorphism in the
ACE gene analyzed by the SNaPshot method.
Results: There were significant differences in left ventricular mass index (LVmassI) value among each sporting discipline
studied. Especially in the athletes of basketball disciplines, indicated the highest LVmassI value than those of other
sporting disciplines studied (p < 0.05). However, there were no significant association between any echocardiographic
data and the G2350A polymorphism in the ACE gene in the both controls and ball game players.
Conclusions: Our data suggests that the G2350A polymorphism in the ACE gene may not significantly contribute
to the changes in cardiac structure and function of ball game players, although sporting disciplines of ball game
players may influence the changes in LVmassI value of these athletes. Further studies using a larger sample size
and other genetic markers in the ACE gene will be needed.
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Background
It is known that athletes who take regular and intensive
physical exercise experience change in the cardiac struc-
ture and function, which is called an athlete’s heart [1], as
a part of physiological adaptation to physical exercise. It
shows basically different symptoms from the abnormal
condition of cardiac structure and function caused by
complication of cardiovascular diseases such as essential
hypertension. That is to say, as to cardiac structure, while
it shows change such as increase in the thickness of ventri-
cular wall caused by increase in the volume of ventricle
and hypertrophy of myocardium, as to cardiac function, it
is known to show increase in stroke volume and decrease
in resting heart rate [2].
Such physiologically adaptive aspect which occurs to
athletes, however, is known to depend on period, intensity
and type of physical exercise and time. In case of athletes
who do aerobic exercises such as marathon or long dis-
tance running repeatedly, an aspect of increase in the left
ventricular internal dimension at end-diastole or increase
in stroke volume is shown. In case of athletes who take
muscle strengthening exercise such as weight lifting or
wrestling, it was known that not only the thickness of left
ventricular posterior wall andi n t e r v e n t r i c u l a rs e p t u m
increase but also the left ventricular mass increases [3].
But, in case of most of sports, it is more likely for ath-
letes to take composite exercises of two types in combina-
tion rather than to do simple aerobic exercise or muscle
strengthening exercise separately and it is especially so in
case of ball game players. According to the results of stu-
dies performed up to now, though it is known that athletes
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cular mass, in cardiac structure, and low resting heart rate
as well as reduction in cardiac output, in cardiac function,
as both types of exercises have influence, it is required to
study effects of composite exercise on cardiac structure
and function by analyzing more fractionized exercise
items as objects because it shows different aspects depend-
ing on the ratio and contents of types of exercises taken.
It is also known that even the athletes who take exer-
cises under similar program with similar intensity for a
similar period show inter-individual difference in the
change of cardiac structure and function, of which the
cause is known to be at least partly attributable to genetic
factors [4].
As it is known that renin-angiotensin system not only
performs an important role in cardiovascular function
through regulation of blood pressure and fluid homeostasis
but also regulates growth of myocardial cells by expressing
components of the system in cardiac cells, the genes encod-
ing components of such physiological systems are attracting
public attention as the potential candidate genes which
affect cardiac structure and function [5]. Among the com-
ponents which consist this system, as angiotensin I convert-
ing enzyme (ACE) is known to not only convert
angiotensin (I), which is a precursor to angiotensin II by
being expressed in diverse body tissues including heart tis-
sue, but also inactivate bradykinin to eventually promote
growth of cardiac cells, the biggest number of studies have
been performed in relation to change in cardiac structure
and function such as left ventricular hypertrophy caused by
complication of cardiovascular diseases such as essential
hypertension as well as left ventricular hypertrophy shown
for athlete groups [6].
It is known that ACE gene which encodes ACE is
located at human chromosome 17 and there exists many
polymorphisms including a polymorphism formed by
insertion/deletion of 287 bp existing in intron 16 of this
gene [7,8]. Though the biggest number of studies have
been performed for I/D polymorphism among various
kinds of polymorphisms existing in ACE gene in relation
to the change in cardiac structure and function including
various cardiovascular diseases and left ventricular hyper-
trophy (LVH) up to now as it shows significant association
with ACE level in tissues and serum, the results of studies
have shown difference between study groups [9-11].
But, though there are a number of other polymorphisms
in ACE gene than I/D polymorphism and further study is
required for clinical association of these polymorphisms,
the situation is that not as many studies as I/D polymorph-
ism have been performed up to now [8,12].
Zhu et al., (2001) have performed association study of
13 kinds of polymorphisms existing in ACE gene with
serum ACE level and blood pressure using them as genetic
markers on 1,343 subjects of 332 Nigerian families. As a
result of the study, they presented that G2350A poly-
morphism existing in exon 17 of this gene had the most
powerful influence on serum ACE level more than that of
I/D polymorphism. This result means that the influence of
I/D polymorphism on serum ACE level may not be direct
genetic effect but may be the result of linkage disequili-
brium with an allele [8]. Accordingly, it is required to
develop new genetic markers which can exercise more
powerful genetic effect and G2350A polymorphism has
risen as one of new alternative genetic markers which can
satisfy such expectation. Recently, result of several studies
on the relation of G2350A polymorphism with cardiovas-
cular diseases, such as essential hypertension and myocar-
dial infarction as well as with left ventricular hypertrophy,
have been reported [13-15].
But, the situation is that, in relation to the influence of
ACE gene on cardiac structure and function shown for
athlete groups, while the majority of study is of those of I/
D polymorphism as subject [4,6,16-20], there is almost no
study on other kinds of polymorphism of this gene includ-
ing G2350A polymorphism.
For this reason, we selected ball game players who are
taking composite exercises such as soccer, baseball, bas-
ketball, volleyball and ice hockey as subjects of this study
and attempted to analyze whether G2350A polymorphism
existing in ACE gene has significant effect on change of
cardiac structure and function shown for athletes engaged
in such game items.
Methods
Study subjects
The participants of this study are consisted of 83 sub-
jects, 50 ball game players (soccer 16, baseball 10, basket-
ball 8, volleyball 8 and ice hockey 8) who have exercise
carrier at least 6 years and 33 controls that do not have
any career of physical exercise. All these participants are
of late teens or early 20s with good health, whose clinical
characteristics are shown in Table 1. Written informed
consent was obtained from all subjects, and this study
was also approved by institutional review board.
Measurements of cardiac structure and function
The anthropological parameters of the participants of
t h i ss t u d yw e r em e a s u r e du s i n gI N - B O D Y3 . 0( B i o -
Space, Co. Ltd., Korea) and the characteristics related to
Table 1 Physical characteristics of study subjects
Variables Controls(n = 33) Athletes(n = 50)
Age(year) 22.3 ± 2.0 21.3 ± 1.2*
Height(cm) 181.3 ± 4.8 182.0 ± 8.0
Weight(kg) 74.1 ± 9.2 76.3 ± 8.0
BMI(kg/m
2) 22.5 ± 2.2 23.0 ± 1.8
Abbreviation: BMI = body mass index. *p < 0.05.
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left ventricular internal dimension at end-diastole
(LVIDd), left ventricular internal dimension at end-
systole (LVIDs), left ventricular mass (LVmass), left ven-
tricular mass index (LVmassI), stroke volume (SV), rest-
ing heart rate (HRrest), cardiac output (CO) and percent
of fractional shortening (FS [%]) were measured using
M-mode echocardiography in accordance with the
instruction established by American Society of Echocar-
diography (ASE) (Figure 1). Also, if the LVmassI value
of the subject is 125 g/m
2 or more, the subject was
judged to have left ventricular hypertrophy [21].
Genetic analysis
In order to analyze G2350A polymorphism existing in
ACE gene, about 3~5 ml of venous blood is taken from
peripheral vein of each subject who participated in this
study, which was then moved to a blood-collecting tube
containing EDTA, an anticoagulant, and stored in refrig-
erator until genetic analysis was performed.
Isolation of total genomic DNA from venous blood of
subjects was performed using Miniban Automatic Blood
DNA Isolation Kit (Bionex, Co. Ltd., Korea), which is an
automated device, and analysis of G2350A polymorph-
ism (rs#4343) existing in ACE1 gene was performed in
SNaPshot method using total genomic DNA of the sub-
jects isolated in above method (Figure 2).
Biochemical assay
After extracting the blood collected from peripheral
veins of subjects to serum isolation tube, serum lipid
and glucose levels were measured from the serum iso-
lated. In case of serum total cholesterol (TC), triglycer-
ide and HDL-cholesterol, concentration was measured
using an automated device, ADVIA 1650 autoanalyzer,
together with enzymatic treatment and colorimetry and
the concentration of serum LDL-cholesterol was esti-
mated using the equation proposed by Friedewald, et al.
1972 [22]. Concentration of plasma glucose was mea-
sured using Hitachi 7180 autoanalyzer together with
enzymatic treatment and colorimetry similarly with
measurement of serum lipid concentration.
Data analysis
Whether observed genotype of G2350A polymorphism
of ACE1 gene is in Hardy-Weinberg equilibrium was
analyzed by c
2-test together with the difference in
Figure 1 An echocardiogram of a subject.
Figure 2 Detection of G2350A polymorphism in the ACE gene
by SNaPshot method. A) GG genotype, B) GA genotype and C) AA
genotype.
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polymorphism of ACE1 gene between the control group
and the ball game players or between players of each
item among athlete groups.
Also, whether the 3 genotypes consisting G2350A poly-
morphism of ACE1 gene have association with echocar-
diographic data and serum biochemical parameters was
analyzed by a one-way ANOVA test. The statistical signifi-
cance level was set as a = 0.05 in this study and all statisti-
cal analysis was performed using SPSSWIN version 17.0
program.
Results
Prevalence of LVH according to sporting disciplines
The result of comparing the frequency of left ventricular
hypertrophy (LVH) between ball game players, though bas-
ketball players showed the highest left ventricular mass
index (LVmassI) and the highest frequency of LVH, no sta-
tistically significant difference was observed between each
item (Table 2). But, all the ball game players who partici-
pated in this study showed higher LVmassI and higher fre-
quency of LVH than the control group. In addition, in the
result of comparing all the ball game players and the con-
trol group, athletes showed statistically higher mean value
of LVmassI than controls (t = -2.175, p = 0.033).
Distribution of the G2350A polymorphism in the ACE
gene
Table 3 shows the difference between the result of investi-
gating distribution of genotype and allele which consists
G2350A polymorphism of ACE1 gene of control group
and ball game player group. Though the result of investi-
gating whether this polymorphism is in Hardy-Weinberg
equilibrium showed that control group (c
2 = 0.2650, df =
1, p = 0.6064), ball game player group (c
2 = 0.0090, df = 1,
p = 0.9251) and all the subjects (c
2 =0 . 0 5 6 0 ,d f=1 ,p=
0.8122) are all in Hardy-Weinberg equilibrium, no statisti-
cally significant difference was observed between geno-
types (c
2 = 1.4375, df = 2, p = 0.4874) and allele frequency
(c
2 = 0.8555, df = 1, p = 0.3550) of two groups. Also, in
the result of examining whether the genotypes consisting
this genetic polymorphism (c
2 = 0.2952, df = 2, p =
0.8628) and allele (c
2 = 0.1089, df = 1, p = 0.7414) show
any significant associations with LVH, neither the geno-
type nor allele showed any significant association with
LVH (Table 4). Table 5 is the result of investigating distri-
bution aspect of frequency of genotype and allele consist-
ing G2350A polymorphism of ACE gene by each exercise
item among ball game player group. The result showed
that there is no statistically significant difference in geno-
types (c
2 = 7.0594, df = 10, p = 0.7198) and allele fre-
quency (c
2 = 2.9359, df = 5, p = 0.7099) of this genetic
polymorphism between game items.
Clinical influences of G2350A polymorphisms in the ACE
gene
The result of investigating whether the 3 genotypes (GG,
GA and AA) consisting G2350A polymorphism of ACE
gene have significant associations with echocardiographic
data and serum biochemical parameters in the control
Table 2 Left ventricular mass index in our subjects
Disciplines No. LVmassI No. of LVH(%)
Soccer 16 117.3 ± 15.8 6(37.5)
Baseball 8 117.8 ± 15.4 3(37.5)
Basketball 10 126.6 ± 15.7 5(50.0)
Volleyball 8 117.4 ± 17.7 2(25.0)
Icehocky 8 121.1 ± 16.6 2(25.0)
Athletes 50 119.9 ± 15.9 18(36.0)
Controls 33 109.5 ± 27.6 5(15.2)
Total 83 115.7 ± 21.8 23(27.7)
There were significant difference in the values of left ventricular mass index
between controls and ball game players (t = -2.175, p = 0.033).
Table 3 Distribution of the G2350A polymorphism in the
ACE gene in controls and ball game players
Genotype Subject No.(%)
Controls(n = 33) Athletes(n = 50)
GG 6(18.2) 7(14.0)
GA 18(54.5) 23(46.0)
AA 9(27.3) 20(40.0)
Total 33(100.0) 50(100.0)
Χ
2 = 1.4375, df = 2, p = 0.4874
Allele Chromosome No.(%)
Control(2n = 66) Athletes(2n = 100)
G 30(45.5) 37(37.0)
A 36(54.5) 63(63.0)
Total 66(100.0) 100(100.0)
Χ
2 = 0.8555, df = 1, p = 0.3550
Table 4 Distribution of the G2350A polymorphism in the
ACE gene by LVH status
Genotype Subject No.(%)
Normal(n = 60) LVH(n = 23)
GG 9(15.0) 4(17.4)
GA 29(48.3) 12(52.2)
AA 22(36.7) 7(30.4)
Total 60(100.0) 23(100.0)
Χ
2 = 0.2952, df = 2, p = 0.8628
Allele Chromosome No.(%)
Normal(2n = 120) LVH(2n = 46)
G 47(39.2) 20(43.5)
A 73(60.8) 26(56.5)
Total 120(100.0) 46(100.0)
Χ
2 = 0.1089, df = 1, p = 0.7414
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Both groups showed no statistically significant associa-
tion with echocardiographic data and serum biochemical
parameters.
Discussion
The objective of this study is to investigate G2350A poly-
morphism distribution of the ACE gene of ball game
players as well as to analyze the effect of genetic poly-
morphism on the cardiovascular function of these subjects.
The result of investigating left ventricular mass index
(LVmassI) and frequency of left ventricular hypertrophy
(LVH) of ball game players such as soccer, baseball, basket-
ball, volleyball and ice hockey, all the ball game players stu-
died showed higher LVmassI value and higher LVH in
average than those of the control group. This can be inter-
preted as result of change in cardiac structure and function
caused by adaptation to inten s i v ee x e r c i s et a k e nb yb a l l
game players for a long period of time [23]. Also, although
no statistical significance has been observed, the basketball
players and ice hockey players showed higher LVmassI
value than players of other ball games, but basketball
players showed the highest frequency of LVH as well. This
result is because of different exercise methods between ball
games which causes the cardiac structure and function to
show different adaptive aspects. That is to say, it seems
that the players of ball games such as basketball and ice
hockey where fierce body fighting and body contact take
place show larger change in adaptive aspect of cardiac
structure and function to physical exercise than players of
other ball games.
As ACE gene has long been attracting public attention
as a genetic predisposition which affects cardiac structure
Table 5 Distribution of the G2350A polymorphism in the
ACE gene in ball game players and controls
Disciplines No. Genotype No.(%) Allele No.(%)
GG GA AA G A
Soccer 16 4(25.0) 6(37.5) 6(37.5) 14(43.8) 18(56.2)
Baseball 8 0(0.0) 5(62.5) 3(37.5) 5(31.3) 11(68.7)
Basketball 10 1(10.0) 4(40.0) 5(50.0) 6(30.0) 14(70.0)
Volleyball 8 2(25.0) 3(37.5) 3(37.5) 7(43.8) 9(56.2)
Icehocky 8 0(0.0) 5(62.5) 3(37.5) 5(31.3) 11(68.7)
Athletes 50 7(14.0) 23(46.0) 20(40.0) 37(37.0) 63(63.0)
Controls 35 6(18.2) 18(54.5) 9(27.3) 30(45.5) 36(54.5)
Total 85 13(15.7) 41(49.4) 29(34.9) 67(40.4) 99(59.6)
Χ
2 7.0594 2.9359
df 10 5
p-value 0.7198 0.7099
Table 6 Influences of the G2350A polymorphism in the
ACE gene on cardiovascular structures and functions in
controls
Variables GG(n = 6) GA(n = 18) AA(n = 9)
Age(year) 21.5 ± 1.4 22.5 ± 2.0 22.4 ± 2.2
Height(cm) 182.3 ± 6.4 180.4 ± 4.0 182.2 ± 5.5
Weight(kg) 75.8 ± 15.7 73.7 ± 7.6 73.6 ± 7.8
BMI(kg/m
2) 22.7 ± 3.6 22.6 ± 2.0 22.1 ± 1.6
AR(cm) 2.8 ± 0.2 2.9 ± 0.2 3.0 ± 0.1
LVIDd(cm) 5.1 ± 0.4 5.2 ± 0.3 5.2 ± 0.3
LVIDs(cm) 3.1 ± 0.4 3.3 ± 0.3 3.2 ± 0.2
LVmass(g) 243.7 ± 143.1 209.6 ± 41.2 203.0 ± 28.6
LVmassI 119.6 ± 55.4 108.5 ± 20.3 104.6 ± 12.0
SV(ml) 85.5 ± 17.4 87.4 ± 13.6 90.9 ± 13.0
HRrest(beat/min) 61.8 ± 10.3 67.7 ± 11.2 66.8 ± 14.3
CO(ml/min) 5271.5 ± 1400.8 5890.6 ± 1186.2 6068.9 ± 1516.9
FS(%) 39.0 ± 3.8 37.1 ± 4.2 38.6 ± 1.8
TC(mg/dl) 139.5 ± 20.0 171.5 ± 73.8 147.0 ± 19.8
TG(mg/dl) 87.5 ± 25.3 167.2 ± 233.0 62.4 ± 30.7
LDL-C(mg/dl) 78.5 ± 20.7 92.3 ± 49.0 85.8 ± 15.2
HDL-C(mg/dl) 43.5 ± 7.1 45.7 ± 7.5 48.7 ± 11.5
Glucose(mg/dl) 87.7 ± 8.4 85.1 ± 9.3 83.2 ± 15.2
Abbreviations: BMI = body mass index, AR = aortic root, LVIDd = left
ventricular internal dimension at end-diastole, LVIDs = left ventricular internal
dimension at end-systole, LVmass = left ventricular mass, LVmassI = left
ventricular mass index, SV = stroke volume, HRrest = resting heart rate, CO =
cardiac output, FS = percent of fractional shortening, TC = total cholesterol,
TG = triglyceride, LDL-C = low density lipoprotein cholesterol, HDL-C = high
density lipoprotein cholesterol.
Table 7 Influences of the G2350A polymorphism in the
ACE1 gene on cardiovascular structures and functions in
ball game players
Variables GG(n = 7) GA(n = 23) AA(n = 20)
Age(year) 21.3 ± 1.4 21.2 ± 1.2 21.4 ± 1.1
Height(cm) 184.4 ± 5.2 179.6 ± 8.5 183.8 ± 7.8
Weight(kg) 77.0 ± 3.5 76.4 ± 9.0 75.9 ± 8.2
BMI(kg/m
2) 22.7 ± 1.1 23.7 ± 2.1 22.4 ± 1.4
AR(cm) 2.9 ± 0.1 3.0 ± 0.3 3.1 ± 0.3
LVIDd(cm) 5.7 ± 0.3 5.4 ± 0.4 5.6 ± 0.3
LVIDs(cm) 3.7 ± 0.2 3.5 ± 0.4 3.5 ± 0.3
LVmass(g) 247.0 ± 35.6 230.6 ± 43.5 240.5 ± 37.4
LVmassI 124.0 ± 19.8 117.6 ± 16.8 121.0 ± 13.7
SV(ml) 113.6 ± 25.9 106.3 ± 25.3 112.0 ± 21.6
HRrest(beat/min) 56.6 ± 5.6 59.6 ± 9.9 56.6 ± 7.5
CO(ml/min) 6531.3 ± 2100.9 6303.9 ± 1725.5 6346.9 ± 1567.9
FS(%) 35.3 ± 2.1 35.9 ± 3.7 36.6 ± 3.1
TC(mg/dl) 141.6 ± 24.5 157.0 ± 26.5 160.6 ± 20.2
TG(mg/dl) 97.1 ± 38.1 105.5 ± 55.1 86.6 ± 39.7
LDL-C(mg/dl) 74.6 ± 18.0 86.8 ± 18.9 87.5 ± 17.5
HDL-C(mg/dl) 47.6 ± 10.6 49.2 ± 9.9 55.8 ± 11.0
Glucose(mg/dl) 90.6 ± 17.4 87.0 ± 11.5 87.1 ± 13.0
Abbreviations: BMI = body mass index, AR = aortic root, LVIDd = left
ventricular internal dimension at end-diastole, LVIDs = left ventricular internal
dimension at end-systole, LVmass = left ventricular mass, LVmassI = left
ventricular mass index, SV = stroke volume, HRrest = resting heart rate, CO =
cardiac output, FS = percent of fractional shortening, TC = total cholesterol,
TG = triglyceride, LDL-C = low density lipoprotein cholesterol, HDL-C = high
density lipoprotein cholesterol.
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studies have been performed, and especially studies to
investigate association of I/D polymorphism existing in
this gene with cardiac structure and function have been
globally performed with diverse groups including athlete
groups as subjects. In most of these studies executed
with patients of cardiovascular disease as subjects, as well
as athletes who mainly take aerobic exercise and athletes
who mainly take resistant exercise, it was reported that
all showed significant association with change in cardiac
structure and function caused by physical exercise
[4,6,16-20,24,25].
However, although I/D polymorphism of ACE gene is
associated with genetic linkage, it has been well unknown
actual genetic effect [7]. Therefore, we believe it is
required to develop other new genetic markers which can
exercise actual effect in this gene. Moreover, as various
single nucleotide polymorphisms (SNP) in ACE gene are
found to have more powerful effect of regulating serum
ACE level than the I/D polymorphism, it will be very
interesting to perform a study to analyze clinical associa-
tion using G2350A polymorphism of ACE gene as the
genetic marker [8].
Up to now, the first study result which analyzed clinical
influence of G2350A polymorphism of ACE gene was the
study performed by Mshmood et al., (2003), which ana-
lyzed association of G2350A polymorphism with essential
hypertension with United Arab Emirates (UAE) population
as subjects, where they reported that this genetic poly-
morphism showed significant association with essential
hypertension [13]. Also, though Iqbal et al., (2004) analyzed
whether this genetic polymorphism showed significant
association with myocardial infarction with Pakistan popu-
lation as subjects, they could notd e t e c ta n ys i g n i f i c a n ta s s o -
ciation [14]. In relation to cardiac structure and function,
Saeed et al., (2005) also analyzed association of this genetic
polymorphism with left ventricular mass (LVH) using UAE
population as subjects. As a result they reported significant
association of this genetic polymorphism with LVH [10].
Furthermore, in the study performed by Pan et al., (2007)
with Chinese population as subjects, we suggested that
G2350A polymorphism of ACE gene may affect change in
cardiac structure and function shown for athlete group. It
showed significant association with LVH appearing as a
complication caused by essential hypertension, though this
genetic polymorphism did not show any significant associa-
tion with essential hypertension [15].
Nevertheless, to our knowledge, as there is no particular
result of study on the influence of G2350A polymorphism
on change in cardiac structure and function appearing to
athlete group because there has not been much genetic
epidemiological study on G2350A polymorphism of ACE
gene in comparison to I/D polymorphism, we analyzed
what influence G2350A polymorphism of ACE1 gene has
o nt h ec h a n g ei nc a r d i a cs t r u c t u r ea n df u n c t i o no fb a l l
game players.
The result of comparing frequency of genotypes and
allele consisting G2350A polymorphism of ACE gene of
the control group and ball game players participating in
this study showed that the genotype frequency observed
was in Hardy-Weinberg equilibrium.
However, when frequency of genotypes and allele of
G2350A polymorphism of this gene of the control group
and ball game players participating in this study was com-
pared, the result showed no significant difference in fre-
quency of two groups and of each ball game players. Also,
in this study, analysis was performed to examine what
influence G2350A polymorphism of ACE gene has on car-
diovascular risk factors such as echocardiographic data
and serum biochemical parameters of the groups. No sta-
tistically significant association has been observed in both
groups. There are some possibilities and limitations that
G2350A polymorphism of ACE gene was not correlated
with athletic performance ability in this study.
O n ep o s s i b i l i t ym a yb ei n t e r p r e t e da st h ed i f f e r e n c e
among ethnic groups. When frequency of A alleles which
consist G2350A polymorphism of ACE1 gene was com-
pared with frequency of A alleles of other healthy ethnic
groups studied up to now, the frequency of A alleles of the
participants of this study was 0.60 showing higher value
than those of UAE population (0.37~0.38) of Pakistan
population (0.32) and Chinese population (0.43) [10,
13~15]. However, our study with Korean population as
subjects did not show any significant genetic association
with cardiac structure and function of ball game players.
Therefore, we think that further study is required to be
performed with other ethnic groups as subjects.
Other limitations could be caused by the number of par-
ticipants and diversity of athletics. In this study, we com-
posed of 35 controls and 50 ball game player. More
participants may be required for this subject to get statisti-
cal significance. We also recruited single athletic players in
this study. We need to perform to check whether genetic
polymorphism of this gene has any significant association
with cardiac structure and function of athletes who take
aerobic exercise such as long distance running or mara-
thon and athletes who take resistant exercises such as
wrestling or weight lifting. Actually, the I/D polymorphism
of ACE gene is associated with endurance athletics such as
marathon runner, longer distance swimmer [26,27].
Therefore, we think that further study on athletes of var-
ious sporting disciplines is also required.
Conclusions
In conclusion, our data suggest that the G2350A poly-
morphism in the ACE gene may not be a useful genetic
marker on cardiac structure and function of ball game
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other candidate genes will be required.
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